n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with fluorouracil in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Half, E; Kuo, MT; Sinicrope, FA; Sun, Y; Tang, XM | 1 |
Cui, ZR; Liang, B; Wang, S; Ye, YJ; Zhang, H; Zhang, YC | 1 |
Adleff, V; Barna, G; Budai, B; Jeney, A; Kralovánszky, J; L Komlósi, V; Pap, E; Réti, A | 1 |
Adleff, V; Budai, B; Jeney, A; Kralovánszky, J; Pap, E; Réti, A | 1 |
Réti, A | 1 |
5 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and fluorouracil
Article | Year |
---|---|
Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase Inhibitors; Caspases; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytochrome c Group; Dinoprostone; Enzyme Activation; Fluorouracil; Humans; Isoenzymes; Membrane Proteins; Mitochondria; Nitrobenzenes; Nucleic Acid Synthesis Inhibitors; Prostaglandin-Endoperoxide Synthases; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sulfonamides; Transfection; Tumor Cells, Cultured | 2002 |
[Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Topics: Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorouracil; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Isoenzymes; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides | 2004 |
Enhancement of 5-fluorouracil efficacy on high COX-2 expressing HCA-7 cells by low dose indomethacin and NS-398 but not on low COX-2 expressing HT-29 cells.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorouracil; HT29 Cells; Humans; Indomethacin; Methylenetetrahydrofolate Dehydrogenase (NADP); Microscopy, Fluorescence; Nitrobenzenes; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thymidylate Synthase | 2009 |
Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Collagen; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dihydrouracil Dehydrogenase (NADP); Dinoprostone; Down-Regulation; Drug Interactions; Extracellular Matrix; Fluorescent Antibody Technique; Fluorouracil; HT29 Cells; Humans; Indomethacin; Nitrobenzenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Xenograft Model Antitumor Assays | 2010 |
[Application of non-steroidal anti-inflammatory drugs to enhance 5-fluorouracil efficacy in experimental systems].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Drug Synergism; Fluorouracil; Gene Expression Regulation, Enzymologic; Humans; Indomethacin; Neoplasms; Nitrobenzenes; Sulfonamides; Transplantation, Heterologous | 2010 |